Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#71 / 200 Total
AVDL - Avadel Pharmaceuticals plc - Stock Price Chart
TickerAVDL [NASD]
CompanyAvadel Pharmaceuticals plc
CountryIreland
IndustryDrug Manufacturers - Specialty & Generic
Market Cap1.54BEPS (ttm)-1.84
P/E-EPS this Y76.67%
Forward P/E23.66EPS next Y247.14%
PEG-EPS past 5Y4.78%
P/S28.00EPS next 5Y15.00%
P/B19.92EPS Q/Q38.12%
Dividend-Sales Q/Q-
Insider Own10.39%Inst Own51.86%
Insider Trans-0.73%Inst Trans-4.52%
Short Float12.21%EarningsMay 08/b
Analyst Recom1.00Target Price23.10
Avg Volume1.20M52W Range9.50 - 19.09
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy. The company was founded on July 21, 1990 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCHUGH THOMAS SChief Financial OfficerJan 16 '24Buy14.502,00029,00080,500Jan 16 04:36 PM
McCamish Mark AnthonyDirectorDec 28 '23Sale14.5375,0001,089,75067,025Dec 29 04:15 PM
MCHUGH THOMAS SChief Financial OfficerAug 14 '23Buy14.452,00028,90078,500Aug 14 05:56 PM
McCamish Mark AnthonyDirectorAug 11 '23Sale14.9328,975432,614142,025Aug 15 04:13 PM
Glass Geoffrey MichaelDirectorAug 10 '23Buy13.4014,000187,60059,000Aug 11 04:00 PM
NVCT - Nuvectis Pharma Inc - Stock Price Chart
TickerNVCT [NASD, RUT]
CompanyNuvectis Pharma Inc
CountryUSA
IndustryBiotechnology
Market Cap118.12MEPS (ttm)-1.37
P/E-EPS this Y9.79%
Forward P/E-EPS next Y-9.30%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B8.42EPS Q/Q8.40%
Dividend-Sales Q/Q-
Insider Own60.91%Inst Own8.32%
Insider Trans0.04%Inst Trans28.35%
Short Float11.46%EarningsMay 07/b
Analyst Recom1.00Target Price22.00
Avg Volume101.82K52W Range5.92 - 18.65
Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BENTSUR RONChairman & CEOMar 18 '24Buy10.295,00051,4503,242,484Mar 19 08:00 AM
BENTSUR RONChairman & CEOOct 10 '23Buy11.086407,0913,237,484Oct 12 04:05 PM
BENTSUR RONChairman & CEOOct 09 '23Buy11.198309,2883,236,844Oct 10 08:30 AM
BENTSUR RONChairman & CEOOct 06 '23Buy11.272502,8183,236,014Oct 10 08:30 AM
BENTSUR RONChairman & CEOOct 05 '23Buy11.091,40015,5263,235,764Oct 06 08:37 AM
MNDR - Mobile health Network Solutions - Stock Price Chart
TickerMNDR [NASD]
CompanyMobile health Network Solutions
CountrySingapore
IndustryHealth Information Services
Market Cap84.32MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own53.46%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float0.30%Earnings-
Analyst Recom1.00Target Price7.00
Avg Volume6.27M52W Range2.31 - 29.50
Mobile-health Network Solutions operates as an investment holding company. The company through its subsidiaries provides telehealth solutions through MaNaDr platform. The platform seeks to offer users the ability to teleconsult with doctors and prescribed and delivered with the medication at their doorsteps. The company's segments include: Telemedicine and Other Services, and Sale of Medicine and Medical Devices. The Telemedicine and Other Services segment includes providing teleconsultation services to patients from both private and public sector. The Sale of Medicine and Medical Devices segment focuses on selling prescription drugs, non-prescription drugs, and healthcare products to clinics and end customers offline and online. The company was founded by Tung Yeng Siaw and Pui Pui Teoh on July 28, 2016 and is headquartered in Singapore.
BHF - Brighthouse Financial Inc - Stock Price Chart
TickerBHF [NASD]
CompanyBrighthouse Financial Inc
CountryUSA
IndustryInsurance - Life
Market Cap2.88BEPS (ttm)-19.04
P/E-EPS this Y17.68%
Forward P/E2.31EPS next Y14.67%
PEG-EPS past 5Y-
P/S0.66EPS next 5Y-1.20%
P/B0.68EPS Q/Q-6.44%
Dividend-Sales Q/Q17.91%
Insider Own1.19%Inst Own82.06%
Insider Trans-6.85%Inst Trans-5.57%
Short Float1.84%EarningsMay 07/a
Analyst Recom3.80Target Price52.50
Avg Volume484.83K52W Range39.24 - 56.24
Brighthouse Financial, Inc. operates as a holding company, which engages in the provision of life insurance and annuities through independent distribution channels and marketing arrangements with a diverse network of distribution partners. It operates through the following segments: Annuities, Life, Run-Off, and Corporate & Others. The Annuities segment product offerings include fixed, structured, income and variable annuities. The Life segment manufactures products to serve its target segments through a broad independent distribution network. The Run-Off segment includes structured settlements, pension risk transfer contracts, certain company-owned life insurance policies, funding agreements and universal life with secondary guarantees. The Corporate & Other segment refers to the general account investments and the separate account assets of the company. The company was founded in June 1863 and is headquartered in Charlotte, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wetzel Paul M.DirectorMay 01 '24Option Exercise0.003,615014,883May 02 04:42 PM
Steigerwalt Eric TPresident and CEOFeb 26 '24Sale46.9625,0001,174,012390,765Feb 28 04:17 PM
Lambert MylesEVP,Chief Mktg.& Dist. OfficerFeb 26 '24Sale47.1110,000471,10061,984Feb 28 04:14 PM
Rosenthal JohnEVP & Chief Investment OfficerFeb 26 '24Sale46.8610,000468,600111,452Feb 28 04:20 PM
Huss VondaEVP & Chief HR OfficerFeb 26 '24Sale46.8510,000468,50027,080Feb 28 04:25 PM
BOF - BranchOut Food Inc - Stock Price Chart
TickerBOF [NASD]
CompanyBranchOut Food Inc
CountryUSA
IndustryPackaged Foods
Market Cap8.08MEPS (ttm)-1.33
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S2.86EPS next 5Y-
P/B3.66EPS Q/Q21.36%
Dividend-Sales Q/Q5472.97%
Insider Own41.33%Inst Own2.09%
Insider Trans0.00%Inst Trans-
Short Float0.68%Earnings-
Analyst Recom-Target Price-
Avg Volume2.18M52W Range1.04 - 6.20
BranchOut Food, Inc. engages in the development, marketing, sale, and distribution of plant-based, dehydrated fruit, and vegetable snacks and powders. Its products include avocado chips, chewy banana bites, brussels sprouts crisps, bell pepper crisps, and pineapple chips. The company was founded by Eric Healy and David Israel on February 21, 2017 and is headquartered in Bend, OR.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dalfonsi JohnDirectorJun 16 '23Buy4.885,00024,40074,803Jul 13 12:56 PM
Healy EricCEOJun 16 '23Buy5.002,00010,000750,083Jun 21 05:04 PM
Dalfonsi JohnDirectorJun 15 '23Buy6.0025,000150,00069,803Jul 13 12:56 PM
PACB - Pacific Biosciences of California Inc - Stock Price Chart
TickerPACB [NASD, RUT]
CompanyPacific Biosciences of California Inc
CountryUSA
IndustryMedical Devices
Market Cap457.53MEPS (ttm)-1.21
P/E-EPS this Y15.59%
Forward P/E-EPS next Y19.52%
PEG-EPS past 5Y-9.76%
P/S2.28EPS next 5Y-1.00%
P/B0.64EPS Q/Q-
Dividend-Sales Q/Q-0.26%
Insider Own4.66%Inst Own97.11%
Insider Trans-1.58%Inst Trans-6.30%
Short Float18.69%EarningsMay 09/a
Analyst Recom2.21Target Price4.82
Avg Volume10.44M52W Range1.25 - 14.55
Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ORDONEZ KATHYDirectorMar 15 '24Option Exercise2.87361,6211,038,682380,216Mar 19 04:24 PM
Meline David WDirectorMar 06 '24Buy4.4040,000176,16040,000Mar 06 05:36 PM
HENRY CHRISTIAN OSee RemarksMar 04 '24Sale4.8714,17769,0562,596,670Mar 06 05:12 PM
Van Oene MarkSee RemarksMar 04 '24Sale4.879,18644,7451,668,826Mar 06 05:26 PM
Kim Susan G.See RemarksMar 04 '24Sale4.875,27525,695712,260Mar 06 05:22 PM
CSTE - Caesarstone Ltd - Stock Price Chart
TickerCSTE [NASD]
CompanyCaesarstone Ltd
CountryIsrael
IndustryBuilding Products & Equipment
Market Cap205.17MEPS (ttm)-3.16
P/E-EPS this Y69.10%
Forward P/E-EPS next Y48.54%
PEG-EPS past 5Y-
P/S0.39EPS next 5Y14.60%
P/B0.67EPS Q/Q-34.52%
Dividend-Sales Q/Q-21.47%
Insider Own40.62%Inst Own33.58%
Insider Trans0.00%Inst Trans-4.95%
Short Float0.17%EarningsMay 08/b
Analyst Recom2.00Target Price5.50
Avg Volume87.44K52W Range3.50 - 6.81
Caesarstone Ltd. operates as a multi material designer, producer and reseller of countertops used in residential and commercial buildings globally. It designs, develops, produces and source engineered quartz, natural stone and porcelain products that offer aesthetic appeal and functionality through a distinct variety of colors, styles, textures, and finishes used primarily as countertops, vanities, and other interior and exterior spaces. The company was founded in 1987 and is headquartered in Haifa, Israel.
CLEU - China Liberal Education Holdings Ltd - Stock Price Chart
TickerCLEU [NASD]
CompanyChina Liberal Education Holdings Ltd
CountryChina
IndustryEducation & Training Services
Market Cap3.87MEPS (ttm)-0.09
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.22EPS next 5Y-
P/B0.59EPS Q/Q-86.05%
Dividend-Sales Q/Q229.64%
Insider Own8.18%Inst Own3.91%
Insider Trans0.00%Inst Trans-96.75%
Short Float0.41%Earnings-
Analyst Recom-Target Price-
Avg Volume111.05K52W Range0.79 - 40.80
China Liberal Education Holdings Ltd., operates as a holding company through its subsidiary, engages in the provision of educational services and programs. It operates through the following segments: Joint Education Programs, Textbook Sales, Overseas Study Consulting, and Technological Consulting for Smart Campus Solutions. The Joint Education Programs segment refers to the Sino-foreign jointly managed academic programs. The Textbook Sales segment includes textbooks and course materials. The Technological Consulting for Smart Campus Solutions segment offers campus intranet solution buildout, school management software customization, smart devices, installation and testing, and school management data collection and analysis. The company was founded on February 25, 2019 and is headquartered in Beijing, China.
AGBA - AGBA Group Holding Limited - Stock Price Chart
TickerAGBA [NASD]
CompanyAGBA Group Holding Limited
CountryHong Kong
IndustryCapital Markets
Market Cap254.41MEPS (ttm)-0.75
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-332.18%
P/S4.69EPS next 5Y-
P/B28.98EPS Q/Q-322.41%
Dividend-Sales Q/Q-
Insider Own0.00%Inst Own0.04%
Insider Trans-Inst Trans0.47%
Short Float0.03%EarningsNov 14/b
Analyst Recom-Target Price-
Avg Volume11.78M52W Range0.32 - 4.29
AGBA Group Holding Ltd. is a wealth and health platform, which engages in the activities span a business-to-business platform, healthcare and wellness services, fintech businesses, as well as financial advisory services. It operates through the following business segments: Distribution Business, Platform Business, Fintech Business, and Healthcare Business. The Distribution Business segment facilitates the placement of insurance, investment, real estate and other financial products and services to the customers, through licensed brokers, in exchange for initial and ongoing commissions. The Platform Business segment provides access to financial products and services to licensed brokers. The Fintech Business segment focuses on the ensemble of fintech investments. The Healthcare Business segment manages an ensemble of healthcare-related investments. The company was founded in 2018 and is headquartered in Hong Kong.
JANX - Janux Therapeutics Inc - Stock Price Chart
TickerJANX [NASD, RUT]
CompanyJanux Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap2.87BEPS (ttm)-1.22
P/E-EPS this Y-7.49%
Forward P/E-EPS next Y-11.18%
PEG-EPS past 5Y-92.62%
P/S393.82EPS next 5Y-
P/B4.38EPS Q/Q28.01%
Dividend-Sales Q/Q-38.87%
Insider Own33.35%Inst Own57.81%
Insider Trans17.29%Inst Trans1.30%
Short Float9.96%EarningsMay 07/a
Analyst Recom1.00Target Price61.12
Avg Volume1.05M52W Range5.65 - 65.60
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Avalon Ventures XI, L.P.10% OwnerNov 13 '23Buy5.87849,8544,988,643849,854Nov 13 07:11 PM
Reardon TigheActing Chief Financial OfficerNov 13 '23Buy5.87849,8544,988,643849,854Nov 15 04:48 PM
Lichter JayDirectorNov 13 '23Buy5.87849,8544,988,643849,854Nov 15 04:46 PM
RA CAPITAL MANAGEMENT, L.P.DirectorJul 19 '23Buy12.46495,0086,167,8008,117,246Jul 21 04:31 PM
134567891011121320